Announcements

  • All
  • Announcements 2009
  • Announcements 2010
  • Announcements 2011
  • Announcements 2012
  • Announcements 2017
  • Announcements 2018
  • Announcements 2019
  • Announcements 2020
  • Announcements 2021
  • Announcements 2022
  • Announcements 2024

Paiania, 4 February 2025 – Lavipharm S.A., a Pharmaceutical, Chemical, and Cosmetic Products Commercial and Industrial Societe Anonyme (hereinafter the “Company”), announces, in accordance with the provisions of Article 19 of Regulation (EU) No. 596/2014 and following a relevant notification received, that on 3 February...

Peania, 23 January 2025 – Lavipharm announces a strategic commercial agreement with the multinational company iNova Pharmaceuticals, the owner of Betadine® and other trusted brands. The new partnership involves the licensing rights of a new antiseptic pharmaceutical OTC product developed by Lavipharm to be commercialized by...

Παιανία, 23 Δεκεμβρίου 2024 - Η Lavipharm A.E., σε συνέχεια της από 14.02.2024 ανακοίνωσής της σχετικά με τη διακοπή της δραστηριότητας  φαρμακαποθήκης και υπηρεσιών logistics προς τρίτους  (3PL) του Ομίλου και τη μεταβίβαση ορισμένων περιουσιακών στοιχείων της θυγατρικής της εταιρείας LAS, ενημερώνει το επενδυτικό κοινό...

Peania, 23 January 2025 – Lavipharm announces a strategic commercial agreement with the multinational company iNova Pharmaceuticals, the owner of Betadine® and other trusted brands. The new partnership involves the licensing rights of a new antiseptic pharmaceutical OTC product developed by Lavipharm to be commercialized by...

Paiania, 19 September 2024 – Lavipharm reports an increase in consolidated sales in H1 2024. Specifically, consolidated Sales from continuing operations amounted to EUR 30.6 million, compared to EUR 29.1 million in the corresponding period of 2023, for an increase of 5.3%. Consolidated Sales, after...

Presentation to the Hellenic Fund and Asset Management Association Paiania, 24 April 2024 – Lavipharm held today its Annual Analysts Briefing, in accordance with the Company’s financial calendar for 2024. The presentation took place at the Athens Exchange to the members of the Hellenic Fund...